Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 8825 - 8832 of 11621 results
With the August Recess Looming, Broad Energy Packages Released
July 28, 2015| Blog| Viewpoint
Emerging State Biosimilar Laws – Reference Chart and Five Issues to Watch
July 28, 2015| Blog| Viewpoint
Inglorious Fraudsters: Unlawfully sourced funds can taint EB-5 investments and result in forfeiture actions
July 28, 2015| Blog| Viewpoint
FTC Commissioners Weigh in on FRAND Debate
July 27, 2015| Alert| Viewpoint
Employing Minors Requires Attention to Laws (SHRM)
July 27, 2015| Blog| Viewpoint
FCC Ruling Addresses Robocalls by Health Care Providers
July 27, 2015| Blog| Viewpoint
Filing EB-5 exemplar petitions before September 30, 2015: strategic considerations
July 24, 2015| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.